| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |